Armata Pharmaceuticals (ARMP) Other financing activities (2019 - 2021)

Armata Pharmaceuticals has disclosed Other financing activities across 3 years of filings, most recently posting -$1.4 million for Q1 2021.

• Other financing activities for Q1 2021 came in at -$1.4 million, down 41.4% year-over-year; the trailing twelve-month figure through Dec 2021 was -$1.4 million (down 148.94% YoY), and the FY2022 annual result was $500000.0, up 135.36% from the prior year.
• Other financing activities came in at -$1.4 million for Q1 2021 at Armata Pharmaceuticals, down from $432000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $432000.0 in Q4 2020 to a low of -$1.4 million in Q1 2021.
• The 3-year median for Other financing activities is -$1.0 million (2019), against an average of -$745500.0.
• Across the five-year window, Other financing activities changed 0.0% in 2020 and sank 41.4% in 2021, its largest moves.
• Armata Pharmaceuticals' Other financing activities stood at -$1.0 million in 2019, then surged by 143.2% to $432000.0 in 2020, then slumped by 427.31% to -$1.4 million in 2021.
• The last three Other financing activities figures came in at -$1.4 million (Q1 2021), $432000.0 (Q4 2020), and -$1.0 million (Q1 2020), per Business Quant data.